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The beneﬁcial effects of insulin and insulin-like growth factor I on
cognition have been documented in humans and animal models.
Conversely, obesity, hyperinsulinemia, and diabetes increase the
risk for neurodegenerative disorders including Alzheimer’s disease
(AD). However, the mechanisms by which insulin regulates synaptic
plasticity are not well understood. Here, we report that complete
disruption of insulin receptor substrate 2 (Irs2) in mice impairs long-
term potentiation (LTP) of synaptic transmission in the hippocampus.
Basal synaptic transmission and paired-pulse facilitation were similar
between the 2 groups of mice. Induction of LTP by high-frequency
conditioning tetanus did not activate postsynaptic N-methyl-D-
aspartate (NMDA) receptors in hippocampus slices from Irs2
2/2
mice, although the expression of NR2A, NR2B, and PSD95 was
equivalent to wild-type controls. Activation of Fyn, AKT, and MAPK in
response to tetanus stimulation was defective in Irs2
2/2 mice.
Interestingly, IRS2 was phosphorylated during induction of LTP in
control mice, revealing a potential new component of the signaling
machinery which modulates synaptic plasticity. Given that IRS2
expression is diminished in Type 2 diabetics as well as in AD
patients, these data may reveal an explanation for the prevalence of
cognitive decline in humans with metabolic disorders by providing
a mechanistic link between insulin resistance and impaired synaptic
transmission.
Keywords: diabetes, insulin receptor signaling, long-term potentiation,
NMDA receptor, synaptic plasticity
Introduction
Memory deﬁcits that develop during the course of Alzheimer’s
disease (AD) have been linked to abnormalities in circulating
insulin levels and/or defects in insulin signaling pathways
(Luchsinger et al. 2004; Rivera et al. 2005; Craft 2007). Con-
sistent with this, administration of insulin improves cognitive
function in these patients (Kern et al. 2001; Reger et al. 2008).
Evidence obtained from epidemiological studies and animal
models suggest that diabetes and other metabolic disorders
increase the risk for development of neurodegenerative dis-
orders (Kuusisto et al. 1997; Vanhanen et al. 2006; Ronnemaa
et al. 2008). Additionally, obesity in middle age predisposes for
impaired cognitive function in the elderly (Elias et al. 2003;
Whitmer et al. 2005).
Despitetheaccumulationofevidencetosupportaphysiological
as well as pathological role for insulin in the hippocampus, the
molecularmechanismsbywhichthishormonemodulatessynaptic
plasticity and memory formation remain poorly deﬁned. Systemic
insulin enters the brain through a receptor-mediated saturable
transport (Baura et al. 1993). Serum insulin-like growth factor I
(IGF-I) also crosses the blood-brain barrier by a transport mecha-
n i s mw h i c hi sr e g u l a t e dd i r e c t l yb yneuronal activity; electrical,
sensory, or behavioral stimulation of neurons can increase IGF-I in
activated regions (Nishijima et al. 2010). IGF-I itself has been
detected in astrocytes and neurons of the central nervous system
(CNS) (Garcia-Segura et al. 1991; Garcia-Estrada et al. 1992). The
receptors for insulin (IR) and IGF-I (IGFIR) as well as other
componentsofthesesignalingpathwaysareexpressedthroughout
the mammalian brain with particularly high concentrations in the
hypothalamus, the hippocampus, and the cerebral cortex (Raizada
et al. 1988; Unger et al. 1989; Pons 1991 #392).
The cellular effects of insulin and IGF-I are mediated
principally by the insulin receptor substrate (IRS) proteins
(Sun et al. 1991). Upon phosphorylation by activated hormone
receptors, IRS proteins recruit various signaling molecules
including phosphoinositide-3-kinase (PI3K), Fyn kinase, and
Grb2 (Sun et al. 1991). The deletion of Irs1 in mice reduces
body size (Araki et al. 1994) and increases lifespan (Selman
et al. 2008), whereas complete disruption of Irs2 causes
diabetes due to insulin resistance and pancreatic b cell failure
(Withers et al. 1999; Burks et al. 2000). IRS1, 2, and 4 are
expressed in neurons and glia throughout the CNS including
cerebral cortex, hippocampus, and hypothalamic nuclei, where
they can be colocalized with the IR or IGFIR (Folli et al. 1994;
Ye et al. 2002).
Learning in rodents alters the expression and phosphoryla-
tion of IR in the CA1 region of the hippocampus (Zhao et al.
1999; Dou et al. 2005). In contrast, experimental diabetes in
animal models is associated with defects of synaptic transmis-
sion (Yamato et al. 2004; Artola et al. 2005; Kamal et al. 2006).
Once in the CNS, insulin modulates components of synaptic
plasticity including recruitment of postsynaptic c-aminobutyric
acid (GABA) receptors (Wan et al. 1997; Vetiska et al. 2007),
endocytosis of a-amino-3-hydroxy-5-methyl-4-isoxazolepro-
pionic acid (AMPA) receptors (Beattie et al. 2000; Lin et al.
2000), and N-methyl-D-aspartate receptor (NMDAR) trafﬁcking
and function (Liu et al. 1995; Skeberdis et al. 2001; van der
Heide et al. 2005). Recently, the IR has also been implicated in
the regulation of synapse density within the Xenopus retina
(Chiu et al. 2008).
 The Authors 2011. Published by Oxford University Press.
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in cognition has been the lack of appropriate animal models;
the majority of published studies have relied on the induction
of diabetes in rodents by treatment with streptozocin, an
antineoplastic agent which inhibits DNA synthesis and is as-
sociated with deleterious side effects including neurotoxicty
(Rivera and Ajani 1998; Imaeda et al. 2002). With the present
study, we have tested whether the insulin-resistant state induced
by complete deletion of Irs2 in mice alters the molecular events
of synaptic transmission. Here, we provide evidence that Irs2
deﬁciency impairs tetanus-induced long-term potentiation (LTP)
in the Schaffer collateral--CA1 region.
Materials and Methods
Animals
The generation and routine genotyping of Irs2-deﬁcient mice have
been described previously (Withers et al 1998). Mice used for the
present studies were maintained on a C57Bl/6 background. All
experiments were performed in compliance with national regulations
regarding animal welfare and were approved by the institutional
committee for ethics and animal use. For routine measurements of
glucose and insulin, mice were fasted for 16 h, and a small quantity of
blood was obtained from the tail vein. Glucose levels were determined
by glucometer (Bayer Elite). Insulin was measured by enzyme-linked
immunosorbent assay (Mercodia, Sweden).
Histology
Brains were ﬁxed in 4% paraformaldehyde. Following embedding in par-
afﬁn, serial sections of 5 microns were prepared. Subsequently, sections
were deparaffinized and stained using a standard Nissl protocol.
Electrophysiology
Transverse brain slices (400 lm thickness) were prepared from female
mice (3 months old) as described previously (Martin and Buno 2003)
and incubated for 1 h at room temperature (21--24 C) in ACSF infused
with 95% O2 and 5% CO2. The artiﬁcal cerebral spinal ﬂuid (ACSF)
contained (in mM): NaCl 124, KCl 2.69, KH2PO4 1.25, MgSO4 2,
NaHCO3 26, CaCl2 2 and glucose 10. Prior to use, ACSF was equilibrated
with 95% O2 and 5% CO2. Slices were transferred to an immersion
recording chamber and perfused (2.5 mL/min) with ACSF. Extracellular
ﬁeld excitatory postsynaptic potentials (fEPSPs) were recorded with
a glass microelectrode (impedances: 2--3 MX; ﬁlled with 1 M NaCl)
positioned in stratum radiatum area CA1. Evoked fEPSPs were elicited
by stimulation of the Schaeffer collateral ﬁbers with an extracellular
bipolar nichrome electrode via a 2100 isolated pulse stimulator (A-M
Systems, Inc., Carlsborg, WA). The stimulation intensity was adjusted to
give fEPSP amplitude that was approximately 50% of maximal fEPSP
sizes. LTP was induced by applying 4 trains (1 s at 100 Hz) spaced 20 s,
and potentiation was measured for 1 h after LTP induction at 0.1 Hz.
The responses to paired-pulse stimulation at different interpulse
intervals (25--400 ms) were used to measure paired-pulse facilitation
(PPF). The mean slope of the fEPSP during the ﬁrst 2 min after the LTP-
inducing tetanus was used to measure post-tetanic potentiation (PTP).
For each experiment, fEPSP slopes were expressed as a percentage of
average pretetanus baseline slope values. To measure the contribution
of NMDA and AMPA receptors to fEPSP, the experiments were
performed in the presence of 50 lM bicuculline to isolate EPSP from
GABAA-mediated inhibitory synaptic transmission. Under these con-
ditions, 6-cyano-7-nitroquinoxaline-2, 3-dione (CNQX; 20 lM) in Mg
2+-
free external solution (Hestrin et al. 1990) or D (–)-2-amino-5-
phosphonopentanoic acid (AP5; 50 lM) was added to pharmacologi-
cally isolate both NMDA and AMPA ﬁeld excitatory postsynaptic current
(fEPSC) components, respectively. Train stimuli at 100 Hz were used to
assess synaptic activation of the AMPA and NMDA receptors by high-
frequency afferent stimulation.
Whole-cell recordings from CA1 hippocampal pyramidal neurons
were made using the ‘‘blind’’ patch-clamp technique as previously de-
scribed (Martin and Buno 2003). Patch electrodes had a resistance of 4--
6M X when ﬁlled with the internal solution that contained (in mM) the
following: cesium gluconate 107.5, 4-(2-hydroxyethyl)-1-piperazinee-
thanesulfonic acid (HEPES) 20, ethyleneglycol-bis(2-aminoethylether)-
N,N,N#,N#-tetra acetic acid (EGTA) 0.2, NaCl 8, TEACl 10, Mg-ATP 4, and
GTP 0.3 at pH 7.3 (adjusted with CsOH), with osmolarities between
280 and 290 mOsm/L. Whole-cell recordings in the voltage-clamp
modes were obtained with an 2400 patch ampliﬁer (A-M Systems). Fast
and slow capacitances were neutralized; series resistance was com-
pensated (ﬃ80%), and membrane potential (Vm) was held at –60 mV.
Data were discarded if the series resistance changed by more than 20%
during an experiment. Evoked EPSCs were elicited by stimulation of
Schaeffer collateral ﬁbers as described previously for the fEPSPs
recording. Data were ﬁltered at 2 KHz and transferred to the hard
disk of a Pentium-based computer using a DigiData 1440A interface and
the pCLAMP 10.0 software (Axon Instruments, Molecular Devices
Corporation, Sunnyvale, CA). For whole-cell recordings, LTP was in-
duced either by tetanic stimulation in current clamp mode or pairing
postsynaptic depolarization to 0 mV with stimulation of presynaptic
Schaeffer collateral ﬁbers at 2 Hz during 60 s (Martin and Buno 2003).
To isolate EPSCs from GABAA-mediated inhibitory synaptic transmis-
sion, experiments were performed in the presence of 50 lM bicucul-
line. With these conditions, we isolated AMPA and NMDA EPSC
components using an experimental approach based on differential
voltage dependence and kinetics (Collingridge et al. 1983; Hestrin et al.
1990; Martin and Pozo 2004). Indeed, when EPSCs are recorded in the
presence of extracellular Mg
2+, the AMPA and NMDA EPSC can be
isolated because at –60 mV, only the fast AMPA EPSC is recorded due to
the voltage-dependent block of the NMDA receptor channel by
extracellular Mg
2+, while at +60 mV, the slower NMDA receptor-
mediated EPSC is present due to the Mg
2+ block relief of the NMDA
receptor channels (Collingridge et al. 1983; Hestrin et al. 1990; Martin
and Pozo 2004). At +60 mV and at delays >50 ms, the AMPA EPSC has
completely disappeared, whereas the slower NMDA EPSC is peaking
and its amplitude can be estimated in isolation (Hestrin et al. 1990;
Martin and Pozo 2004). All drugs were purchased from Sigma (St Louis,
MO) except CNQX, AP5, and bicuculline that were from Tocris
Cookson (Bristol, UK). Statistical differences were established using the
2-tailed Student’s t-test.
Immunoprecipitation and Western Blotting
Hippocampus slices were prepared for electrophysiology as described
above. Prior to the induction of LTP, slices were collected and
processed as nonstimulated controls. Following the induction of LTP,
hippocampal slices were collected at 5 and 30 min and frozen imme-
diately in liquid N2. Tissue was lysed in RIPA buffer by polytron, and
homogenates were clariﬁed by centrifugation at 12 000 3 g for 10 min.
Protein determination was by the Bradford assay. Immunoprecipita-
tions were performed using 500 lg of total protein. The immune
complexes were collected on protein A-agarose or protein G-agarose
beads and subjected to sodium dodecyl sulfate--polyacrylamide gel
electrophoresis (SDS-PAGE). Gels were transferred to Immobilon
membranes and incubated with one of the following antibodies: anti-
NR2B (Upstate), anti-phosphotyrosine (Upstate), anti-p-AKT (Cell Signal-
ing), anti-MAPK (Santa Cruz Biotechnology Inc.), anti-IR (Santa Cruz
Biotechnology Inc.), anti-IGFIR (Cell Signaling). Westerns were developed
by ECL (Pierce), ﬁlms scanned and immunoreactive bands quantiﬁed with
the Alpha Imager program.
Isolation of Postsynaptic Densities
Mice were sacriﬁced by cervical dislocation, and the hippocampus was
dissected from each brain. The ﬁxed angle protocol of Villasana et al.
(2006) was adapted for tabletop ultracentrifuge (Beckman Coulter
Optima TLX-120) using 4 hippocampi of each genotype. Brieﬂy,
hippocampi were pooled and lysed by homogenization in ice-cold
buffer (320 mM sucrose, 4 mM HEPES, pH 7.3) to which a cocktail of
inhibitors was added (Complete, Roche) An aliquot of the homogenate
was collected for western analysis of total lysate (T) and the remainder
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resulting pellet was discarded and the supernatant was centrifuged
9200 3 g for 15 min. The pellet containing crude synaptosomes was
resuspended in hypotonic lysis buffer and centrifuged for 20 min at
250 000 3 g. The pellet containing the postsynaptic densities (PSD) was
solubilized (50 mM Tris, 150 mM NaCl, 2.5 mM ethylenediaminetetra-
acetic acid, 2.5 mM EGTA, pH 7.4, containing protease inhibitors), and
protein concentration was measured by Bradford assay. Forty micro-
grams of protein from the total lysate, cytosolic fraction, and PSD
fraction were separated by SDS-PAGE, and western analysis was per-
formed as described above.
Results
Basal Synaptic Transmission Is Preserved in Irs2
–/– Mice
We ﬁrst analyzed basal synaptic transmission by applying
isolated stimuli of increasing intensity to the Schaffer collaterals
(Fig. 1A). Input/output curves for extracellular fEPSP were
indistinguishable between slices from Irs2
–/– mice and wild-
type (WT) controls. For a range of stimulation intensities, the
slopes of Irs2
–/– fEPSP responses were not signiﬁcantly different
from the fEPSP responses of WT slices (P > 0.05, n = 6 mice of
each genotype, at least 3 slices per mouse, Fig. 1B). Likewise,
measurements of the ﬁber volleys amplitude from Irs2
–/– and
WT slices were similar (P > 0.05, n = 6 mice of each genotype,
at least 3 slices per mouse, Fig. 1C), and there was no difference
in an input/output curve (Fig. 1D). We also investigated
presynaptic function to exclude the possibility that the ab-
sence of IRS2 alters the probability of neurotransmitter release.
PPF ratios of fEPSP slopes at interstimulus intervals ranging
from 25 to 400 ms were normal in the Irs2
–/– mice (P > 0.05, n
= 6 mice of each genotype, at least 3 slices per mouse, Fig.
1E,F). Collectively, these results indicate that Irs-2 deﬁciency
does not modify the basal synaptic transmission at the pre-
synaptic or postsynaptic level.
Loss of IRS2 Function Disables LTP at the Postsynaptic
Level
Given that insulin resistance is associated with impaired neu-
ronal function, we used the Irs2 transgenic model to assess
synaptic plasticity at Schaffer collateral--CA1 synapse in the
hippocampus using a high-frequency conditioning tetanus to
induce LTP. LTP is the sustained increase in synaptic strength
obtained after a high-frequency conditioning stimulus and is a
compelling model for the synaptic mechanism underlying some
forms of learning and memory (Malenka and Nicoll 1999).
Baseline responses were monitored for 10--30 min before con-
ditioning and were found to be stable. Tetanic conditioning
revealed a marked difference in the ability of hippocampus
slices from Irs2
–/– mice to support LTP, with potentiation of
fEPSP being signiﬁcantly reduced in slices from transgenic
animals as compared with WT (n = 6 mice of each genotype, at
least 3 slices per mouse, P < 0.001, Fig. 2A). To evaluate
whether the lack of tetanus-induced LTP might reﬂect in-
sufﬁcient cumulative depolarization during tetanic stimulation,
LTP was induced by pairing postsynaptic depolarization with
presynaptic stimulation via patch-clamp techniques in whole-
cell recordings (see Materials and Methods). This LTP was also
completely impaired in Irs2
–/– mice (n = 4 mice of each
genotype, at least 2 slices per mouse, P < 0.001, Fig. 2B),
indicating that IRS2 signaling is required to maintain synaptic
plasticity at Schaffer collateral--CA1 synapse in the hippocam-
pus. To test the possibility that increased inhibition causes the
impaired LTP in Irs2
–/– mice, tetanic conditioning was applied
to control and transgenic slices in the presence the GABAA
receptor antagonist bicuculline (50 lM). However, under these
conditions, the defective LTP persisted in Irs2
–/– mice (Fig. 2C),
demonstrating that increased inhibition was not responsible for
the inability to induce LTP in the absence of IRS2 signals.
Moreover, PTP of the fEPSP revealed no signiﬁcant differences
between slices from mutant and control animals (mean percent
of baseline before tetanus: Irs2
+/+ 98.7 ± 1.2%, n = 6 mice; Irs2
–/–
99.6± 0.8%, n = 6 mice; following tetanus: Irs2
+/+ 256.1± 15.4%,
n = 6 mice; Irs2
–/– 217.2 ± 21.1%, n = 6 mice). PTP is postulated
to indicate presynaptic function, reﬂecting a period of enhanced
transmitter release caused by the loading of the presynaptic
terminals with calcium ions during tetanic conditioning (Zucker
1989). Therefore, these results demonstrate clearly that the
impairment of LTP observed in the hippocampus of Irs2
–/– is due
to defects at the postsynaptic level without a reduction of
neurotransmitter release. Moreover, the impaired LTP was not
related with diabetic complications in the Irs2
–/– animals since 8-
week-old females with normal glucose and insulin levels were
Figure 1. Basal synaptic transmission and PPF at CA1 synapses are not altered in
Irs2
 /  mice. (A) Representative fEPSP recorded in the stratum radiatum and evoked
by stimulation of the Schaffer collateral--commissural pathway with different
intensities in WT (top) and Irs2
 /  (bottom) mice. (B) fEPSP slopes are comparable
between Irs2
þ/þ (ﬁlled circle, n 5 6 mice) and Irs2
 /  (open circle, n 5 6 mice) for
a given range of stimulus intensities. (C) Fiber volley amplitudes are similar between
Irs2
þ/þ (ﬁlled circle, n 5 6) and Irs2
 /  (open circle, n 5 6) mice for a given range
of stimulus intensities. (D) Input/output relationships for control (ﬁlled circle, n 5 6)
and transgenic (open circle, n 5 6) mice. Data are presented as mean ± standard
error of the mean. (E) Representative fEPSP recorded in stratum radiatum of slices
from Irs2
þ/þ (top) and Irs2
 /  (bottom) mice at different interstimulus intervals. (F)
PPF of fEPSPs was similar in both Irs2
þ/þ (n 5 6) and Irs2
 /  (n 5 6) mice. The
mean slope of the paired EPSP is plotted against interpulse interval.
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Fig. 1A,B). Deletion of Irs-2 produces diabetes in mice due to
reduced beta cell mass and peripheral insulin resistance;
however, the development of diabetes in this model displays
a sexual dimorphism which affects males earlier and more
severely than females (Burks et al. 2000). Given the critical role
of IRS-2 in brain development (Schubert et al. 2003), we
examined the formation of the hippocampus but found no gross
morphological differences between genotypes (Supplementary
Fig. 1C).
Irs2
–/– Mice Display an Inadequate Synaptic Activation of
NMDA Receptors
LTP in the hippocampus is expressed as an increase of the
slope and amplitude of the fast component of EPSP mediated by
the AMPA subtype of glutamate receptor (Schubert et al. 2003).
However, it is generally agreed that induction of the classical
LTP requires the activation of postsynaptic NMDA receptors
(Bliss and Collingridge 1993). Consistent with this, the NMDAR
antagonist AP5 completely abolished the induction of LTP in
WT and Irs2
–/– mice (n = 4 mice of each genotype, at least 2
slices per mouse, Fig. 3A), conﬁrming that this type of LTP
indeed requires NMDA receptor activation. To quantify the
relative contributions of AMPA- and NMDA receptor-mediated
synaptic components under our experimental conditions,
patch-clamp recordings from whole cells were made during
the ﬁrst 30 min following tetanic stimulation under current
clamp mode, using an experimental approach based on dif-
ferent voltage dependence and kinetics (see Materials and
Methods). The AMPA receptor-mediated component of the
evoked EPSC (AMPAEPSC) measured at –60 mV increased 5 min
after tetanic stimulation in WT and Irs2
–/– samples (Fig. 3B,C).
However, although the AMPAEPSC amplitude was maintained 30
min after tetanus in WT (Fig. 3B,C), these recordings returned
Figure 2. Synaptic plasticity at CA1 synapses is altered in the absence of IRS2
signals. (A) Summary of time course of mean fEPSPs slope in hippocampus slices
from WT (ﬁlled circle, n 5 6 mice) and Irs2
 /  (open circle, n 5 6 mice) in basal
conditions and following induction of LTP. At least 2 slices from each hippocampus
used. Data were normalized for each slice with respect to the average slope recorded
during baseline. The insert depicts a representative superimposed recording taken
before and after LTP induction in both groups of mice. (B) Representative EPSC
averages (inset traces) and summary data of LTP induced by pairing postsynaptic
depolarization during 60 s with presynaptic stimulation (2 Hz) using patch-clamp
techniques, in WT (ﬁlled circle, n 5 4m i c e )a n dI r s 2
 /  (open circle, n 5 4m i c e ) .( C)
The impaired LTP in Irs2
 /  (ﬁlled circle, n 5 4) mice was insensitive to the
suppression of inhibition with 50 lM of the GABAA receptor antagonist bicuculline (Bic).
Figure 3. Relative contributions of AMPA and NMDA receptors to the impaired LTP
of Irs2-deﬁcient mice. (A) Expression of LTP was blocked by 50 lM AP5, an
antagonist of NMDA receptors, in both WT and (ﬁlled circle, n 5 4 mice) and Irs2
 / 
(open circle, n 5 4 mice) hippocampus. (B) Representative EPSC means in WT (top
traces) and Irs2
 /  (bottom traces) slices recorded at  60 (AMPAEPSCs) and þ60
mV (NMDAEPSCs) in basal conditions and 5 and 30 min after LTP induction. (C)
Summary of mean AMPAEPSCs peak amplitudes (recorded at  60 mV) in WT (ﬁlled
bar, n 5 4) and Irs2
 /  (open bar, n 5 4) mice. Whereas AMPAEPSCs in WT slices
were signiﬁcantly potentiated at 30 min following LTP induction, they were reduced to
basal values in Irs2
 /  slices. (D) Summary graph depicting mean NMDAEPSCs peak
amplitudes (recorded at þ60 mV at 100 ms delay) in WT (ﬁlled bar, n 5 4) and
Irs2
 /  (open bar, n 5 4) mice. NMDAEPSCs in Irs2
 /  were signiﬁcantly reduced at
30 min following LTP induction. Error bars indicate standard error of the mean (SEM).
Signiﬁcant differences were established at ***P\0.001. (E) Ratios of amplitudes of
the whole-cell currents recorded at  60 and þ60 mV. The NMDA receptor-
dependent responses (measure at 100 ms delay) were similar in the Irs2
þ/þ (ﬁlled
bar) and Irs2
 /  (open bar) slice. Error bars indicate SEM.
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–/– animals. The amplitude of NMDAR-
mediated component (NMDAEPSC), measured at +60 mV and at
delays of 100 ms, was not signiﬁcantly different from baseline
values at 5 and 30 min after tetanus in WT slices (n = 4 mice of
each genotype, at least 3 slices per mouse, Fig. 3B,D), in
agreement with previous observations (Kullmann 1994; Nicoll
and Malenka 1999; Poncer and Malinow 2001). This potenti-
ation of the AMPAEPSC component, without changes to the
NMDAEPSC component, characterizes the classical LTP of
Schaeffer collateral EPSCs in CA1 pyramidal neurons (Kullmann
1994; Nicoll and Malenka 1999; Poncer and Malinow 2001).
However, with slices from Irs2
–/– mice, the NMDAEPSC declined
signiﬁcantly to below baseline values 30 min after tetanus (63 ±
21%, n = 4 mice of each genotype, at least 3 slices per mouse, P
< 0.05, Fig. 3B,D). The observed deﬁcit of the NMDAR-
mediated component of EPSC in Irs2
–/– slices could be the
result of either alterations to the number or properties of the
synaptic NMDA receptors or inadequate activation of NMDA
receptors during the high-frequency stimulation. To distin-
guish between these possibilities, we ﬁrst examined the ratio of
NMDAR-mediated to AMPA receptor-mediated synaptic cur-
rents, which controls for slice-to-slice variability in the number
of synapses activated (Saal et al. 2003). First, the AMPA
receptor-mediated synaptic current amplitude was measured
at a holding potential of –60 mV. Then, recording from the
same cell, the NMDAR-mediated current was recorded at
a holding potential of +60 mV and its amplitude was measured
at delays >50 ms (see Materials and Methods). The calculated
ratio was similar between Irs2
–/– and WT mice (Fig. 3B,E). We
next investigated whether synaptic activation of AMPA or
NMDA receptors was normal using fEPSP recordings during
a stimuli train (100 Hz) where the NMDA component was
isolated with CNQX in Mg
2+-free solution and the AMPA
component with AP5 in normal ACSF (Hestrin et al. 1990;
Martin and Pozo 2004). Under these conditions, the recordings
for the AMPA receptor-mediated component of fEPSP were
similar between WT and Irs2
–/– slices (Fig. 4A,B). In contrast,
we observed that the percentage of the second, third, and
fourth fEPSP slope over the ﬁrst fEPSP in the train of isolated
NMDA component was signiﬁcantly smaller in the Irs2
–/– when
compared with that of WT slices (second fEPSP: 137.5 ± 19.6%
for Irs2
+/+ vs. 59.6 ± 19.5% for Irs2
–/–, P < 0.05; third fEPSP: 45.3
± 15.7% for Irs2
+/+ vs. 7.2 ± 12.1% for Irs2
–/–, P < 0.01; 35.3 ±
11.2% for Irs2
+/+ vs. 5.7 ± 9.5% for Irs2
–/– to fourth fEPSP, P <
0.01; n = 4 mice of each genotype, at least 3 slices per mouse,
Fig. 4C,D). Collectively, these results demonstrate that Irs2 null
mice display inadequate activation of postsynaptic NMDARs.
Tyrosine Phosphorylation of NR2B Subunit of NMDA
Receptors Is Reduced in Irs2 Null Mice
We next performed a series of experiments to elucidate the
contributions of NMDAR subtypes to the defect observed in Irs2
null mice. We recorded pharmacologically isolated NMDAR-
mediated EPSCs by using whole-cell voltage clamp in the
presence of 50 lM bicuculline and 20 lMC N Q Xi nM g
2+-free
external solution. Application of ifenprodil (3 lM), an NR2B-
subtype-speciﬁc antagonist, reduced the NMDAR-mediated
EPSCs in WT mice (Fig. 5A;5 1 . 8± 7%; n = 4m i c eo fe a c h
genotype, at least 2 slices per mouse). In contrast, the same
treatment had only a minor effect on NMDAR-mediated EPSCs of
Irs2 null mice (Fig. 5A;9 1 . 9± 9%; n = 4m i c eo fe a c hg e n o t y p e ,a t
least 2 slices per mouse). These results strongly suggest that
NR2B-containing NMDARs play an important role in the synaptic
plasticity modulated by IRS2 signaling.
Various lines of evidence indicate that the NR2B subunit of
NMDA receptors undergoes tyrosine phosphorylation during
Figure 4. Inadequate activation of synaptic NMDA receptors during the high-frequency stimulation in the Irs2
 /  transgenic mice. (A) Representative ﬁeld responses of AMPA
component evoked by a 100 Hz train during 200 ms in Irs2
þ/þ (top traces) and Irs2
 /  (bottom traces), recorded in the presence of 50 lM AP5 to block NMDA component. (B)
Summary data showing mean AMPA isolated fEPSP slopes in Irs2
þ/þ (ﬁlled bar; n 5 4) and Irs2
 /  (open bar; n 5 4) mice, that were plotted against the number of the stimulus
during 100 Hz train. The fEPSP slope at the 4 initial stimuli was calculated as the percentage of the ﬁrst fEPSP slope. (C) Representative ﬁeld responses of NMDA component
evoked by a 100-Hz train during 200 ms in Irs2
þ/þ (top tracings) and Irs2
 /  (bottom tracings), recorded in the presence of 20 lM CNQX to block AMPA component. (D)
Summary data showing mean NMDA isolated fEPSP slopes in IRS-2
þ/þ (ﬁlled bar; n 5 4) and IRS-2
 /  (open bar; n 5 4) mice. The fEPSP slope was signiﬁcantly smaller in the
IRS-2
 /  for the second, third, and fourth stimuli. Signiﬁcant differences were established at *P \ 0.05 and **P \ 0.01.
Cerebral Cortex August 2012, V 22 N 8 1721induction of LTP (Rostas et al. 1996). The NR2B contains 3
tyrosine phosphorylation sites which are targeted by Fyn
(Nakazawa et al. 2001). To assess the tyrosine phosphorylation
of NR2B in IRS-2 deﬁcient mice, hippocampal slices were
collected prior to induction of LTP and at 5 and 30 min after
tetanic stimulation. These slices were then lysed and analyzed
by western blotting. Consistent with previous reports (Rostas
et al. 1996), tetanus increased signiﬁcantly the tyrosine phos-
phorylation of NR2B after 5 min in WT slices (Fig. 5B), and this
activation persisted until 30 min. However, in hippocampus
slices from Irs2
–/– mice, tetanus stimulation did not produce
tyrosine phosphorylation of NR2B at either of the time points
(Fig. 5B).
The failure to trigger tyrosine phosphorylation of NR2B with
tetanus stimulation could not be attributed to reduced expres-
sion of this subunit since the levels detected by western blot-
ting in hippocampus slices were equivalent between WT and
Irs2 mutant mice (Fig. 5B,C). Given that NR2B appeared to be
inactive in Irs2
–/– mice, we assessed whether increased
expression of NR2A might reﬂect a compensatory mechanism
in this model. However, western blotting analysis of hippo-
campus lysates revealed that the expression of NR2A (as well as
NR2B) was equivalent between both genotypes (Fig. 5C).
Another potential explanation for the impaired function of
NR2B is failed targeting to the PSD in the hippocampus of
Irs2
–/– animals. The PSD is a structural network of receptors, ion
channels, and signaling proteins which are required for
synaptic function (Feng and Zhang 2009). To investigate this
possibility, PSD fractions were prepared from hippocampus of
both experimental groups. Aliquots of total lysate, cytosol, and
PSD were analyzed by western blotting. PSD95, a scaffolding
protein which forms complexes with NMDAR (Sheng 2001),
was used as a marker of PSD. Due to the signiﬁcant enrichment
of PSD95 in the PSD fraction, a longer exposure (40 vs. 15 s)
was required to detect this marker as well as NR2A and NR2B
in an equivalent amount of total lysate; however, using this
exposure time, the ECL detection of these proteins in the PSD
was saturated. Other markers which were used to assess the
quality and quantity of the preparations included AKT (cytosolic
fraction) and GAPDH (loading control for total lysate). In-
terestingly, no differences were detected between WT and Irs2
-/-
with respect to the targeting of NR2A, NR2B, or PSD95 to the
PSD. Thus, these results suggest that impaired activation of NR2B
in response to tetanus in hippocampus slices of Irs2 KO cannot
be attributed to a general failure of the targeting of NR2B to the
PSD.
Figure 5. Irs2 deﬁciency impairs activation of the NR2B subunit of NMDA receptors. (A) Inhibition of NR2B-containing NMDAR-mediated EPSCs by ifenprodil. Plots represent
normalized NMDAR-mediated EPSCs recorded by whole-cell voltage clamp (Vm 5  65 mV) before and after application of ifenprodil (3 lM) as indicated. The experiment was
performed in the presence of 50 lM bicuculline, 20 lM CNQX in Mg
2þ-free external solution. Values represent mean ± standard error of the mean (n 5 4 mice of each
genotype, at least 2 slice per mouse). Right panel contains sample EPSC traces recorded at different time points. (B) Hippocampus slices were collected before (0 min) and after
(5 and 30 min) induction of LTP with tetanus stimulation. Following immunoprecipitation with anti-NR2B antibodies, western blotting was performed with anti-phosphotyrosine
antibodies (PY) as well as with anti-NR2B. Western blots were scanned and quantiﬁed by Alpha Imager. Tetanus stimulation did not induce tyrosine phosphorylation of NR2B in
slices from Irs2
 /  animals. Graph represents data from 3 independent experiments, with n of 9 WT and 9 Irs2
 /  mice. (C) Western analysis of NMDAR expression. Fifty
micrograms of individual hippocampus lysates were probed with antibodies speciﬁc for either NR2A or NR2B. Anti-b-tubulin was used to conﬁrm equal protein loading. The
images reﬂect a 40 s exposure of ECL detection. The results shown are representative of 2 independent experiments (WT 5 4 mice; Irs2
 /  5 4 mice). (D) Western analysis of
subcellular fractions isolated from hippocampus. Four hippocampi of each genotype were pooled to prepare PSD as described in Materials and Methods. Forty micrograms of the
indicated fractions were used for immunoblotting. T: total lysate, C: cytosol. With the exception of the image labeled ‘‘PSD95 longer exposure,’’ the exposure time for detecting
the indicated proteins by ECL was 15 s. Due to the signiﬁcant enrichment of NR2A, NR2B, and PSD95 in the PSD fraction, a longer exposure (40 s) was required to detect these
proteins in the total lysate as illustrated by the additional image of PSD95.
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Associated with LTP and Synaptic Transmission
To relate the impaired LTP to a molecular mechanism, we next
examined intracellular signal transduction during the induction
of LTP. Upon activation of insulin and IGF-I receptors by ligand
binding, these receptor tyrosine kinases phosphorylate IRS
proteins, enabling them to recruit and activate other signaling
molecules (White 1997). Fyn is a nonreceptor tyrosine kinase
which mediates the effects of insulin in various tissues
(Davidson et al. 1994; Mastick and Saltiel 1997). Interestingly,
ablation of Fyn in mice impairs LTP without alterations to basal
synaptic transmission and PPF (Grant et al. 1992). Upon insulin
stimulation, Fyn associates with phosphorylated tyrosine
residues of IRS proteins via its src homology (SH) 2 domain
(Sun et al. 1996). Therefore, we evaluated the activation of Fyn
in response to tetanus stimulation in hippocampus slices from
WT and Irs2-deﬁcient mice. At 5 min poststimulus, the
activation of Fyn as detected by anti-phosphotyrosine anti-
bodies was increased signiﬁcantly in WT slices (Fig. 6A) and
persisted at 30 min, although the levels were slightly lower
than at 5 min. In sharp contrast, tetanus stimulation did not
induce tyrosine phosphorylation of Fyn in Irs2
–/– slices at 5 min;
however, after 30 min, the levels of tyrosine-phosphorylated
Fyn were comparable to those detected in WT slices. Thus,
these results suggest that IRS2 signals are required for the
proper temporal phosphorylation of Fyn in response to high
trains of tetanus stimulation.
Once phosphorylated on speciﬁc tyrosine residues, IRS pro-
teins also recruit and activate PI3-K through a direct interaction
with the p85 catalytic subunit (Myers et al. 1992). Interestingly,
PI3K activity and its subsequent phosphorylation of Akt are also
necessary for expression of LTP (Man et al. 2003; Wang et al.
2003). In our analysis of signal transduction pathways, we
observed that the levels of phosphorylated Akt increased 5 min
after the induction of LTP in slices from WT mice (Fig. 6B)a n d
returned to basal levels after 30 min. However, in hippocampus
slices from Irs2
–/– mice, tetanus did not produce an increase of
phosphorylated AKT at 5 min, perhaps owing to the fact that the
basal levels of phospho-Akt were higher than in slices from WT
controls (Fig. 3B). In peripheral tissues such as liver and muscle,
Irs2-deﬁciency has been associated with elevated basal levels of
PI3K and AKT which impairs the ability of insulin or IGF-I to
activate these pathways (Withers et al. 1998).
The MAPK/ERK pathway mediates certain forms of NMDA-
dependent LTP (English and Sweatt 1996; Winder et al. 1999;
Kanterewicz et al. 2000; Shalin et al. 2006). Insulin can activate
MAPK/ERK either directly via its receptor or by the IRS/Grb2/
ras complex (Avruch 1998). Analysis of ERK phosphorylation in
Figure 6. Failed LTP is associated with impaired signaling in hippocampus slices from Irs2
 /  mice. (A) Hippocampus slices were collected before (0 min) and after (5 and 30
min) induction of LTP with tetanus stimulation. Protein lysates were prepared and immunoprecipitated with anti-Fyn antibodies. Subsequent western blotting with anti-PY revealed
a signiﬁcant delay in the tyrosine phosphorylation of Fyn in hippocampus slices from Irs2 null mice. Graph represents data from 3 independent experiments, n 5 9 WT mice and 9
Irs2
 /  mice. (B) Fifty micrograms of hippocampus lysates were loaded for western blotting. Induction of LTP was coincident with activation of Akt in WT but not Irs2
 /  slices
due to high basal levels phospho-Akt. Graph represents data from 5 independent experiments, n 5 15 WT and 15 Irs2
 /  mice. (C) Activation of MAPK in response to LTP
induction was not sustained at 30 min in IRS-2 deﬁcient mice. Graph represents data from 7 independent experiments, n 5 14 WT and 12 Irs2
 /  mice. (D) Fifty micrograms of
hippocampus lysates were loaded for western analysis of the expression levels of the insulin receptor (IR), IGF-I receptor (IGFIR), and IRS1. No differences were noted between
WT and Irs2 null mice. (E) Following lysis of hippocampus slices as described above, samples were immunoprecipitated for IRS2. Western blotting with anti-PY antibodies
revealed that induction of LTP with tetanus stimulation induces the tyrosine phosphorylation of IRS2. Data are representative of 2 independent experiments, n 5 6 WT and 6 Irs2
null mice.
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were no differences between WT and Irs2
–/– mice; however,
after 30 min, phospho-ERK levels remained elevated in WT sam-
ples (Fig. 6C), whereas they returned to basal levels in Irs2
–/–
slices. Thus, these results demonstrate that IRS-2 signals are
essential for sustained activation of ERK during the induction of
LTP by tetanic stimulation.
The defects in these signaling pathways could not be ex-
plained by alterations to the expression of the IR, IGF-IR, or
IRS-1 since the levels of these proteins in hippocampus were
equivalent between WT and Irs2
–/– mice (Fig. 6D). Given that
the ability of IRS proteins to orchestrate intracellular signaling
is dependent on their tyrosine phosphorylation, we next
examined the possibility that induction of LTP by high trains
of tetanus stimulation promotes the tyrosine phosphorylation
of IRS2. Thus, IRS2 was immunoprecipitated from WT
hippocampus slices which had been subjected to tetanus
stimulation, and the immune complexes were analyzed sub-
sequently by western blotting using anti-phosphotyrosine
antibodies. Interestingly, the tyrosine phosphorylation of IRS2
was increased signiﬁcantly at 5 min poststimulus but returned
to basal levels after 30 min (Fig. 6E). Collectively, these results
are consistent with a role for IRS2 in recruiting and activating
other signaling pathways implicated in the expression of LTP
including Fyn kinase and Akt.
Discussion
Previous studies have demonstrated that IRS2 is required for
neuronal development (Schubert et al. 2003) and for CNS-
mediated regulation of appetite (Burks et al. 2000). Whole-
body deletion of Irs2 causes insulin resistance by disabling
insulin signaling pathways; Irs2-deﬁciency causes hyperphagia
and obesity due to impaired insulin signaling in speciﬁc
populations of hypothalamic neurons (Kubota et al. 2004;
Choudhury et al. 2005). In the present study, we have identiﬁed
IRS2 as a novel component of the signaling apparatus which
mediates synaptic plasticity in the hippocampus. Through a
series of electrophysiological studies, we have demonstrated
that expression of LTP is signiﬁcantly impaired in Irs2 null
mice. This impairment of LTP occurs at the postsynaptic level
without a reduction to neurotransmitter release since we did
not detect signiﬁcant differences in paired-pulse facilitation,
synaptic fatigue, or PTP between WT and Irs2
–/– mice.
Several observations from our study demonstrate that IRS2
signals may participate in the activation of postsynaptic NMDA
receptors during high-frequency stimulation. First, Irs2
–/– mice
did not present alterations to the number or properties of the
synaptic NMDARs. Second, when we isolated speciﬁcally the
NMDAEPSC component of LTP, we observed a signiﬁcant
decline to below baseline values 30 min after tetanus in IRS-
2
–/– mice, while no changes were noted in WT control animals.
Finally, the fEPSPs slopes of the isolated NMDA component in
a 100 Hz train (the frequency that induces LTP under our
experimental conditions) were signiﬁcantly smaller in the Irs2
–/–
slices when compared with those registered in control slices.
Importantly, the ratio of NMDA/AMPA synaptic currents, which
controls for slice-to-slice variability in the number of synapses
activated (Saal et al. 2003), was similar between Irs2
–/– and
control mice. Modulation of synaptic transmission appears to be
a speciﬁc role for IRS-2 since mice deﬁcient for IRS1, 3, or 4 have
no reported CNS defects (Araki et al. 1994; Liu et al. 1999).
The present observation that IRS2 signals participate directly
in LTP raises questions about precisely how this docking mol-
ecule modulates synaptic plasticity. Our analysis of the signaling
pathways during induction of LTP in hippocampus slices has
revealed that the absence of IRS2 impairs tyrosine phosphory-
lation of NR2B and activation of Fyn kinase, AKT, and MAPK in
hippocampal slices. Interestingly, insulin and IGF-I regulate these
pathways by SH2 domains (Schlessinger et al. 1992). By
employing IRS proteins to engage other signaling molecules,
the IR circumvents stoichiometric constraints encountered by
receptors that directly recruit SH2 proteins to their autophos-
phorylation sites; one IRS molecule can simultaneously bind
various SH2-containing molecules (e.g., Fyn, p85 PI3K, and
Grb2). Given that IRS proteins are not tethered to the plasma
membrane, the recruitment of these molecules to IRS2 may
serve the critical function of relocalizing activated signaling
pathways to a site within the neuron where they can modulate
synaptic plasticity.
Mice deﬁcient for Fyn kinase display impaired LTP and def-
icits of spatial learning (Grant et al. 1992). However, no studies
to date have addressed the upstream signals that activate Fyn
during the induction of LTP. We observed that Fyn was fully
phosphorylated 5 min after the application of tetanus trains in
normal mice, whereas this did not occur until 30 min in hip-
pocampus slices from Irs2
–/– mice. Given that Fyn is activated
upon the interaction of its SH2 domain with phosphorylated
IRS proteins (Sun et al. 1996), our ﬁndings suggest that IRS2
plays an important role in regulating the activity of this kinase.
Thus, when IRS2 signals are absent or reduced, the delayed
postsynaptic activation of Fyn may impair the ability of this
kinase to phosphorylate the NR2B subunits of NMDA receptors,
an event which potentiates NMDA channel activity (Yu et al.
1997; Xu et al. 2006). Our studies demonstrate that that the
expression of NR2A and NR2B as well as their targeting to PSDs
is preserved in Irs2-deﬁcient mice, excluding these potential
alterations as explanations for the impaired LTP.
Irs2 deﬁciency has been shown previously to impair the
activation of PI3K/AKT in liver and muscle of Irs2
–/– mice
(Withers et al. 1998). PI3K has been linked to the insertion of
AMPA receptors at activated CA1 synapses (Man et al. 2003)
and to the inhibition of GSK3b activity during the induction of
LTP (Peineau et al. 2007), whereas AKT activity is required for
the cell surface expression of GABA receptors (Wang et al.
2003). Hence, our observation that conditioning tetanus is
unable to activate AKT in hippocampus slices of Irs2-deﬁcient
mice suggests that IRS2 serves as an important upstream ele-
ment for the regulation of synaptic PI3K/AKT signaling.
Surprisingly, induction of LTP in WT hippocampus slices
increased tyrosine phosphorylation of IRS2. Given that IRS
proteins are phosphorylated exclusively by receptors for in-
sulin and IGF-I, this observation requires further study to
determine precisely how IRS2 becomes activated during
application of conditioning tetanus to hippocampus slices.
Depolarization of rat neuronal cultures by potassium ions has
been reported to stimulate a signiﬁcant release of insulin
(Clarke et al. 1986). Therefore, it is possible that induction of
LTP in the Schaeffer collateral ﬁbers by tetanus trains causes
neurons and/or astrocytes to release insulin and/or IGF-I into
their surroundings and this, in turn, induces the phosphoryla-
tion of IRS2 via the activation of postsynaptic insulin receptors.
Alternatively, physiological levels of systemic insulin may
modulate synaptic plasticity in vivo by promoting the
IRS2 Signals Modulate Synaptic Plasticity
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LTP. Whole-body deletion of Irs2 causes insulin resistance and
other metabolic abnormalities by disabling insulin signaling
pathways; Irs2-deﬁcient mice eat more than control mice due
the presence of insulin resistance in speciﬁc populations of
hypothalamic neurons (Burks et al. 2000; Kubota et al. 2004;
Chodbury et al 2005). Similarly, failed LTP in the hippocampus of
Irs2 null mice may also reﬂect a form of insulin resistance which
undermines the proper activation of AKT and Fyn in the PSD.
Studies of human subjects as well as experimental animal
models demonstrate that diabetes adversely affects learning
and memory (Biessels et al. 1996; Desrocher and Rovet 2004;
Messier 2005; Stranahan et al. 2008). Our present results
suggest that IRS2 expression and/or function may represent an
important link between metabolic disorders and synaptic
plasticity. Irs2 expression is signiﬁcantly reduced in pancreatic
islets from humans with Type 2 diabetes (Gunton et al. 2005),
consistent with a critical role for IRS2 in maintaining normal
sensitivity to insulin. Interestingly, reduced expression and/or
function of insulin and IGF-I signaling molecules have been
detected in AD brains (Craft 2007; Moloney et al. 2008). By
establishing a molecular connection between systemic insulin/
IGF-I resistance and impaired synaptic transmission, our
observations suggest that lifestyle changes or pharmacological
agents that target the expression and/or function of IRS2 may
prevent neuronal dysfunction in patients with metabolic
diseases.
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